
Calls to make low-cost IVF more accessible in Australia
Following a round of intrauterine insemination (IUI), where prepared sperm is placed directly into a woman's uterus, Ms Murphy was thrilled to finally see a positive result for the first time.
But almost eight weeks later, she discovered the pregnancy was ectopic and would have to be removed.
In the resulting surgery she lost one of her fallopian tubes and doctors told her she would need to undergo IVF in order to successfully fall pregnant in future.
"I just bawled and kept asking if I could still have my babies ... it just crushed me," Ms Murphy told AAP.
The couple began to explore their IVF options and quickly realised the cost per round would be between $10,000 and $15,000.
"We both just decided we wanted to throw everything at it and worry about the costs later," Ms Murphy said.
For many people hoping to become parents, cost-of-living pressures are deterring them from fertility treatment.
With Australia posting a record-low fertility rate in 2024, experts say low-cost IVF options will be crucial to addressing the decline in births.
The average number of children born per woman was 1.51 in 2024, well below the 1.8 in 2014.
In 2022, almost 109,000 IVF cycles were performed resulting in the birth of 20,058 babies.
Almost half of Australians surveyed by Connect IVF said fertility services were not affordable.
Connect IVF was one of the few affordable clinics in an industry that had been driven by a wave of corporatisation, director Brendan Ayres said.
"(Our clinics) see a broad section of Australians and we get a disproportionate number of people from lower socioeconomic groups who need fertility treatment," he said.
"We also have a number of patients who have been to other clinics and paid tens of thousands of dollars without success and are at their financial wits' end."
Ms Murphy discovered Connect IVF by a chance internet search and the clinic was able to accommodate her for her next menstrual cycle.
"The cost was substantially lower than other clinics because they bulk-billed the IVF cycle," she said.
"It also allowed us to pay for a private obstetrician during my pregnancy, which we wouldn't have been able to afford if we'd had to pay up to $15,000 for the IVF."
Ms Murphy ended up with four embryos from the round, which led to her three-year-old son Beau and one-year-old daughter Maia.
"I love being a mum. It was such a journey and if I could have just looked into the future and seen my babies it would have made such a difference," she said.
"People might think if they pay more money there might be more chance of having a baby, but I have friends who have paid thousands more than us with no success."
While the Australian government supports parts of IVF through Medicare, it was not linked to the consumer price index, meaning the gap increased over time, Mr Ayres said.
"Australia is a world leader in the technology of IVF but the funding hasn't followed," he said.
"There also needs to be additions to Medicare item numbers to expand to all areas such as donor IVF which currently isn't covered."

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Sky News AU
10 minutes ago
- Sky News AU
Australians pay $2 billion to see their doctor
New data has revealed visiting the GP is costing more than ever. Australians paid more than $2 billion over the past year, with $151 million being spent in June alone. Out-of-pocket fees are at a record high, averaging more than $48 per visit. The federal government says help is coming, but critics say patients are still paying the price.

Sydney Morning Herald
3 hours ago
- Sydney Morning Herald
ASX set to fall, Wall Street mixed; Microsoft, Meta surge
Stocks indexes were mixed in afternoon trading on Wall Street after a health care sector slide offset some of the gains from a rally among big tech companies. The S&P 500 was up less than 0.1 per cent, holding just below the record high it set on Monday. The Dow Jones Industrial Average fell 88 points, or 0.2 per cent. The technology-heavy Nasdaq rose 0.3 per cent and is on track for a record. The Australian sharemarket is set to retreat, with futures at 5.10am AEST pointing to a loss of 52 points, or 0.6 per cent, at the open. The ASX lost 0.2 per cent on Thursday. The Australian dollar was fetching 64.33 US cents at 5.25am. Health care stocks were the biggest drag on the market after the White House released letters asking big pharmaceutical companies to cut prices and make other changes in the next 60 days. Eli Lilly & Co. fell 2 per cent, UnitedHealth Group slid 4.9 per cent and Bristol-Myers Squibb was 4.5 per cent lower. Roughly 70 per cent of stocks in the S&P 500 were losing ground, but big technology stocks with hefty values helped temper the impact of losses in health care and other sectors. Loading Technology stocks rose following results from big companies showcasing advancements in artificial intelligence. Facebook and Instagram's parent company Meta Platforms surged 11.9 per cent after it crushed Wall Street's sales and profit targets even as the company continues to pour billions into artificial intelligence. Microsoft jumped 4.1 per cent after also posting better results than analysts expected. The software pioneer also gave investors an encouraging update on its Azure cloud computing platform, which is a centrepiece of the company's artificial intelligence efforts.

The Age
3 hours ago
- The Age
ASX set to fall, Wall Street mixed; Microsoft, Meta surge
Stocks indexes were mixed in afternoon trading on Wall Street after a health care sector slide offset some of the gains from a rally among big tech companies. The S&P 500 was up less than 0.1 per cent, holding just below the record high it set on Monday. The Dow Jones Industrial Average fell 88 points, or 0.2 per cent. The technology-heavy Nasdaq rose 0.3 per cent and is on track for a record. The Australian sharemarket is set to retreat, with futures at 5.10am AEST pointing to a loss of 52 points, or 0.6 per cent, at the open. The ASX lost 0.2 per cent on Thursday. The Australian dollar was fetching 64.33 US cents at 5.25am. Health care stocks were the biggest drag on the market after the White House released letters asking big pharmaceutical companies to cut prices and make other changes in the next 60 days. Eli Lilly & Co. fell 2 per cent, UnitedHealth Group slid 4.9 per cent and Bristol-Myers Squibb was 4.5 per cent lower. Roughly 70 per cent of stocks in the S&P 500 were losing ground, but big technology stocks with hefty values helped temper the impact of losses in health care and other sectors. Loading Technology stocks rose following results from big companies showcasing advancements in artificial intelligence. Facebook and Instagram's parent company Meta Platforms surged 11.9 per cent after it crushed Wall Street's sales and profit targets even as the company continues to pour billions into artificial intelligence. Microsoft jumped 4.1 per cent after also posting better results than analysts expected. The software pioneer also gave investors an encouraging update on its Azure cloud computing platform, which is a centrepiece of the company's artificial intelligence efforts.